← SynDRA
FOSIFLOXURIDINE NAFALBENAMIDE
SynDRA canonical compound SYN0034191 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
| Primary target(s) | TYMS |
| Mechanism of action | thymidylate synthase inhibitor |
| Indication | colorectal cancer |
| Disease area | oncology |
All known targets
Mechanisms of action (all sources)
- thymidylate synthase inhibitor
- TYMS INHIBITOR
Cross-references
Synonyms
- Fosifloxuridina nafalbenamida
- NUC-3373
- CPF-373
- NUC-3073
- CHEMBL2181367
- EX-A4413
- DB14859
- J3.616.613D
- UNII-4YO6QT3SZ9 component BIOWRMNRHMERIO-XWVUVRNUSA-N
- L-Alanine, N-(-2'-deoxy-2',2'-difluoro-p-1-naphthalenyl-5'-cytidylyl)-, phenylmethyl ester
- NUC 3373
- 4YO6QT3SZ9
- fosifloxuridina nafalbenamida
- RefChem:141390
- fosifloxuridinum nafalbenamidum
- Nucleotide Analog NUC-3373
- NUC3373
- 5-FU Analog Prodrug NUC-3373
- Phosphoramidate-FUDR-MP Prodrug NUC-3373
- Fosifloxuridine nafalbenamide [USAN]
- UNII-4YO6QT3SZ9
- WHO 10749
- orb1304263
- SCHEMBL29358451
- GLXC-24142
- AKOS040753337
- BN179651
- NUC3373(Fosifloxuridine nafalbenamide)?
- FOSIFLOXURIDINE NAFALBENAMIDE [INN]
- HY-109115
- CS-0078080
- FOSIFLOXURIDINE NAFALBENAMIDE [WHO-DD]
- D12388
- G17609
- T33762
Look up FOSIFLOXURIDINE NAFALBENAMIDE in the interactive SynDRA portal →